A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants.

Summary

The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of AZD0233 following single and multiple ascending dose (SAD and MAD) administration in healthy participants.

Timeline

Start

2024-04-01

Primary completion

2025-12-30

Completion

2025-12-30

Outcome

Outcome not reported

Stopped: “The study has been terminated due to adverse finding in a non-clinical, chronic toxicology study.”

Drugs

Indications